880155 | ALC-0159
Methoxypolyethyleneglycoloxy(2000)-N,N-ditetradecylacetamide

ALC-0159
Methoxypolyethyleneglycoloxy(2000)-N,N-ditetradecylacetamide
Methoxypolyethyleneglycoloxy(2000)-N,N-ditetradecylacetamide, or ALC-0159, is a methoxypolyethylene glycol (PEG-2000) conjugated lipid and is designed to enhance the stability and biocompatibility of LNP drug delivery systems.
By forming a hydrophilic shield, ALC-0159 significantly reduces immune recognition to increase circulation time and improve bioavailability. As a key component in mRNA-based vaccines, this PEGylated lipid carries out a fundamental function in efficient nanoparticle encapsulation and intracellular delivery. This makes it indispensable in cutting-edge pharmaceutical and gene therapy applications.
Applications
ALC-0159 is a foundational element in LNPs for mRNA-based vaccines, including COVID-19 formulations. It is also vital for stabilizing nanoparticle formulations in nucleic acid and small-molecule drug delivery.
Other notable applications include its ability to improve stability, bioavailability, and reduced immunogenicity in CRISPR, siRNA, and antisense oligonucleotide uses, as well as driving next-generation RNA-based therapies, which enables improved systemic circulation and controlled release.
Packaging
Avanti Research™ provides ALC-0159 in powder (25mg, 50mg, 100mg, 200mg, 500mg, and 1g) for precise, reproducible results.
Trust Avanti to deliver industry-leading products that advance your research forward!
And whether you’re in preclinical research or commercial production, Croda Pharma can provide GMP-certified lipid options to meet your needs. Explore their pharmaceutical-grade offerings for high-quality, scalable solutions.
C121H243NO47
C 58.98%, H 9.94%, N 0.57%, O 30.51%
CAS Registry Number is a Registered Trademark of the American Chemical Society
Schoenmaker, Linde et al. “mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.” International journal of pharmaceutics vol. 601 (2021): 120586. doi:10.1016/j.ijpharm.2021.120586
PubMed ID: 33839230- Certificate of Analysis (Lot No. 880155P-50MG-A-010 and 7050PKA010)
- Certificate of Analysis (Lot No. 880155P-1G-A-010 and 7050PQA010)
- Certificate of Analysis (Lot No. 880155P-25MG-A-010 and 7050PJA010)
- Certificate of Analysis (Lot No. 880155P-100MG-A-010 and 7050PLA010)
- Certificate of Analysis (Lot No. 880155P-200MG-A-010 and 7050PNA010)
- Certificate of Analysis (Lot No. 880155P-500MG-A-010 and 7050PPA010)
- Certificate of Analysis (Lot No. 880155P-1G-B-010 and 7050PQB010)
- Certificate of Analysis (Lot No. 880155P-100MG-A-011 and 7050PLA011)
- Certificate of Analysis (Lot No. 880155P-200MG-A-011 and 7050PNA011)
- Certificate of Analysis (Lot No. 880155P-1G-C-011 and 7050PQC011)
- Certificate of Analysis (Lot No. 880155P-1G-A-011 and 7050PQA011)
- Certificate of Analysis (Lot No. 880155P-50MG-B-010 and 7050PKB010)
- Certificate of Analysis (Lot No. 880155P-25MG-B-010 and 7050PJB010)
- Certificate of Analysis (Lot No. 880155P-1G-B-011 and 7050PQB011)
- Certificate of Analysis (Lot No. 880155P-25MG-C-010 and 7050PJC010)
- Certificate of Analysis (Lot No. 880155P-100MG-B-010 and 7050PLB010)
- Certificate of Analysis (Lot No. 880155P-200MG-B-011 and 7050PNB011)
- Certificate of Analysis (Lot No. 880155P-500MG-B-011 and 7050PPB011)
- Certificate of Analysis (Lot No. 880155P-50MG-A-011 and 7050PKA011)
- Certificate of Analysis (Lot No. 880155P-500MG-C-011 and 7050PPC011)
- Certificate of Analysis (Lot No. 880155P-25MG-D-010 and 7050PJD010)
- Certificate of Analysis (Lot No. 880155P-25MG-A-011 and 7050PJA011)
- Certificate of Analysis (Lot No. 880155P-500MG-E-011 and 7050PPE011)
- Certificate of Analysis (Lot No. 880155P-1G-D-011 and 7050PQD011)
- Certificate of Analysis (Lot No. 880155P-1G-E-011 and 7050PQE011)
- Certificate of Analysis (Lot No. 880155P-25MG-B-011 and 7050PJB011)